Form 4: Boundless Bio's Chief Scientific Officer, Christian Hassig, Acquires 95,000 Stock Options
SEC Form 4 Filing
Christian Hassig, Chief Scientific Officer of Boundless Bio, Inc., acquired 95,000 stock options on January 22, 2025, vesting monthly starting February 1, 2025.
Summary
- Christian Hassig, the Chief Scientific Officer of Boundless Bio, Inc. (BOLD), filed a Form 4 on January 23, 2025.
- The filing reports a transaction that occurred on January 22, 2025, where Hassig acquired 95,000 stock options.
- These options have an exercise price of $2.57 and expire on January 21, 2035.
- The stock options vest in 48 substantially equal monthly installments beginning on February 1, 2025.
- Following the reported transaction, Hassig directly owns 95,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock option grants, which is a common practice. It suggests confidence from the executive but doesn't provide strong positive or negative signals.
Positives
- The acquisition of stock options by a key executive like the Chief Scientific Officer can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates activity by a key executive at Boundless Bio.
Stakeholder Impact
- Shareholders may view the stock option grant as a sign of alignment between management and shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 01/22/2025 | Date of transaction: Christian Hassig acquired 95,000 stock options. |
| 01/23/2025 | Date of Form 4 filing. |
| 02/01/2025 | Vesting start date for the stock options. |
| 01/21/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.